U-Blot® Research Grade ZelecimentCat. No. WA3832Request quote
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade ZelecimentCat. No. WA3832
U-Blot® Research Grade zeclantamigCat. No. WA3831
U-Blot® Research Grade ZatuximabCat. No. WA3830
U-Blot® Research Grade zarutatugCat. No. WA3829
U-Blot® Research Grade zareprumigCat. No. WA3828
U-Blot® Research Grade ZaptuzumabCat. No. WA3827
U-Blot® Research Grade ZansecimabCat. No. WA3826
U-Blot® Research Grade ZanolimumabCat. No. WA3825
U-Blot® Research Grade ZanidatamabCat. No. WA3824
U-Blot® Research Grade zamubafusp alfaCat. No. WA3823
U-Blot® Research Grade zamristobartCat. No. WA3822
U-Blot® Research Grade ZampilimabCat. No. WA3821